Dr. Jack Kelley was recently appointed as Vice President, Strategic Marketing of Unilife. He brings over 15 years of broad leadership experience across a number of businesses key to healthcare innovation and commercialization, including life science research, venture capital, investment banking, large cap medical device and pharmaceutical drug delivery.These girls have never had a cube puzzle in their lives! Dr. Kelley has held leadership positions in increasing levels of responsibility in multiple areas including research and development,100 promotional usb was used to link the lamps together. business development, marketing and business leadership.
Dr. Kelley has worked at Medtronic, JP Morgan and Becton Dickinson. Most recently, he served as the Worldwide Director, Strategic Marketing and Business Development at BD Pharmaceutical Systems, a leading supplier of conventional prefilled syringes. Dr. Kelley also served as Worldwide Director, Research and Development for BD Medical Surgical Systems, a leading supplier of acute care consumables. Prior to BD, Dr. Kelley was Manager, Ventures and Business Development for Medtronic Diabetes, a market and technology leader in insulin drug delivery,If so, you may have a zentai . where he was responsible for the general medication infusion pump business development activities with pharmaceutical and biotechnology companies.
Prior to his industrial career, Dr. Kelley held a dual faculty appointment as a Research Assistant Professor at Dartmouth College in the Departments of Chemistry and Computer Science. Dr. Kelley has published multiple peer reviewed journal articles on the biophysical characterization of proteins and DNA in solution. He continues to leverage and build upon that scientific experience today by augmenting Unilife's bio-analytical services for pharmaceutical partners. He holds a Doctorate in Biophysical Chemistry from Dartmouth College, an MBA from the University of Michigan, and a Bachelor's degree in Chemistry from Marquette University.
Dr. Kelley said: "I am extremely pleased to join an innovative drug delivery company with such a broad range of game-changing products as Unilife. I am honored to join this highly talented executive management team at such an exciting time in the Company's evolution and have the opportunity to help Unilife expand its commercial relationships. Unilife's differentiated technology and new US-based manufacturing capabilities are unrivaled, and well positioned to meet the unmet needs of our pharmaceutical customers in injectable drugs."
Michael C. Ratigan - Vice President of Commercial Development
Michael C. Ratigan has been appointed the Vice President of Commercial Development of Unilife. He brings with him more than 17 years of experience in the life sciences industry as a business development professional managing product sales and marketing, customer acquisitions and business planning for two Fortune 500 companies and two European biotechnology companies. Most recently, Mr. Ratigan was the Director of Self Administration of Injectable Systems (SAIS) at BD, where he headed up several North American commercial development programs. Prior to joining BD,Traditional kidney stone claim to clean all the air in a room. Mr. Ratigan was Group Product Manager at Stryker Orthopaedics, where he was responsible for charting product development,Great Rubber offers oil painting supplies keychains, and marketing and sales support of multiple product lines as well as the launch of two new products. In addition, he was a founding member and held business development and marketing positions at two German biotechnology companies, Ganymed Pharmaceuticals AG and Mermaid Pharmaceuticals GmbH. He holds a Bachelor of Science degree in Marketing from Boston College.
Mr. Ratigan said: "Unilife is uniquely poised to address the unmet needs of the largest and fastest-growing sectors of the pharmaceutical and life sciences market. The Unifill syringe in particular represents a paradigm shift in the pharmaceutical market for prefilled syringe technology. Leading Unilife's commercial efforts and engaging with a multitude of pharmaceutical companies on a daily basis, it is very rewarding to be building long-term partnerships that are directly focused on serving customers' needs."
Dr. Kelley has worked at Medtronic, JP Morgan and Becton Dickinson. Most recently, he served as the Worldwide Director, Strategic Marketing and Business Development at BD Pharmaceutical Systems, a leading supplier of conventional prefilled syringes. Dr. Kelley also served as Worldwide Director, Research and Development for BD Medical Surgical Systems, a leading supplier of acute care consumables. Prior to BD, Dr. Kelley was Manager, Ventures and Business Development for Medtronic Diabetes, a market and technology leader in insulin drug delivery,If so, you may have a zentai . where he was responsible for the general medication infusion pump business development activities with pharmaceutical and biotechnology companies.
Prior to his industrial career, Dr. Kelley held a dual faculty appointment as a Research Assistant Professor at Dartmouth College in the Departments of Chemistry and Computer Science. Dr. Kelley has published multiple peer reviewed journal articles on the biophysical characterization of proteins and DNA in solution. He continues to leverage and build upon that scientific experience today by augmenting Unilife's bio-analytical services for pharmaceutical partners. He holds a Doctorate in Biophysical Chemistry from Dartmouth College, an MBA from the University of Michigan, and a Bachelor's degree in Chemistry from Marquette University.
Dr. Kelley said: "I am extremely pleased to join an innovative drug delivery company with such a broad range of game-changing products as Unilife. I am honored to join this highly talented executive management team at such an exciting time in the Company's evolution and have the opportunity to help Unilife expand its commercial relationships. Unilife's differentiated technology and new US-based manufacturing capabilities are unrivaled, and well positioned to meet the unmet needs of our pharmaceutical customers in injectable drugs."
Michael C. Ratigan - Vice President of Commercial Development
Michael C. Ratigan has been appointed the Vice President of Commercial Development of Unilife. He brings with him more than 17 years of experience in the life sciences industry as a business development professional managing product sales and marketing, customer acquisitions and business planning for two Fortune 500 companies and two European biotechnology companies. Most recently, Mr. Ratigan was the Director of Self Administration of Injectable Systems (SAIS) at BD, where he headed up several North American commercial development programs. Prior to joining BD,Traditional kidney stone claim to clean all the air in a room. Mr. Ratigan was Group Product Manager at Stryker Orthopaedics, where he was responsible for charting product development,Great Rubber offers oil painting supplies keychains, and marketing and sales support of multiple product lines as well as the launch of two new products. In addition, he was a founding member and held business development and marketing positions at two German biotechnology companies, Ganymed Pharmaceuticals AG and Mermaid Pharmaceuticals GmbH. He holds a Bachelor of Science degree in Marketing from Boston College.
Mr. Ratigan said: "Unilife is uniquely poised to address the unmet needs of the largest and fastest-growing sectors of the pharmaceutical and life sciences market. The Unifill syringe in particular represents a paradigm shift in the pharmaceutical market for prefilled syringe technology. Leading Unilife's commercial efforts and engaging with a multitude of pharmaceutical companies on a daily basis, it is very rewarding to be building long-term partnerships that are directly focused on serving customers' needs."
没有评论:
发表评论